Prostate Cancer Nuclear Medicine Diagnostics Market to Hit $1,315.66 million by 2028 at 10.6% CAGR - Says, The Insight Partners
July 25, 2022 10:30 ET
|
The Insight Partners
New York, July 25, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on "Prostate Cancer Nuclear Medicine Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global...
Radiopharmaceuticals Market ($13.81Bn by 2028) Growth Forecast at 9% CAGR During (2021-2028) - COVID-19 Impact and Global Analysis by TheInsightPartners.com
August 24, 2021 15:06 ET
|
The Insight Partners
New York, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Radiopharmaceuticals Market: Key InsightsAccording to our new research study on “Radiopharmaceuticals Market to 2028 – Global Analysis and Forecast – by...
Global Radiopharmaceuticals in Nuclear Medicine Market to Surpass US$ 10.6 Billion by 2026 – Coherent Market Insights
May 10, 2019 08:30 ET
|
CMI
SEATTLE, May 10, 2019 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global radiopharmaceuticals in nuclear medicine market was valued at US$ 4,986.4 million in 2017 and is projected to...